FDA
approval
· 2022-04-29
FDA Approved: NORTREL 7/7/7 (28 DAY REGIMEN) — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved a supplemental application for Nortrel 7/7/7 (28-day regimen), a combined oral contraceptive containing norethindrone and ethinyl estradiol, ma…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORTREL 7/7/7 (28 DAY REGIMEN) (NORETHINDRONE AND ETHINYL ESTRADIOL)